- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1546-0096
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Glucose metabolism in systemic juvenile idiopathic arthritis ; volume:20 ; number:1 ; day:29 ; month:7 ; year:2022 ; pages:1-8 ; date:12.2022
Pediatric rheumatology ; 20, Heft 1 (29.7.2022), 1-8, 12.2022
- Urheber
-
Suppasit, Papatsorn
Vilaiyuk, Soamarat
Poomthavorn, Preamrudee
Pongratanakul, Sarunyu
Khlairit, Patcharin
Mahachoklertwattana, Pat
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12969-022-00714-6
- URN
-
urn:nbn:de:101:1-2022101515060024653355
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:26 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Suppasit, Papatsorn
- Vilaiyuk, Soamarat
- Poomthavorn, Preamrudee
- Pongratanakul, Sarunyu
- Khlairit, Patcharin
- Mahachoklertwattana, Pat
- SpringerLink (Online service)
Ähnliche Objekte (12)
Genetic architecture distinguishes systemic juvenile idiopathic arthritis from other forms of juvenile idiopathic arthritis: clinical and therapeutic implications
Novel IL10 gene family associations with systemic juvenile idiopathic arthritis
Extreme thrombocytosis in systemic juvenile idiopathic arthritis. A case report
Mouse models of systemic juvenile idiopathic arthritis and macrophage activation syndrome
The role of extracellular histones in systemic-onset juvenile idiopathic arthritis
Tocilizumab-induced hypofibrinogenemia in patients with systemic-onset juvenile idiopathic arthritis
Biologic switching patterns among children with non-systemic juvenile idiopathic arthritis
The epigenetic determinants for systemic juvenile idiopathic arthritis phenotyping and treatment response
Oral or Parenteral Methotrexate for treatment of Non- Systemic Juvenile Idiopathic Arthritis
Inflammatory bowel disease following anti-interleukin-1-treatment in systemic juvenile idiopathic arthritis
Sequential Tocilizumab and Tofacitinib Treatment for Systemic Juvenile Idiopathic Arthritis: a Case Report
Systemic juvenile idiopathic arthritis in French Afro-Caribbean children, a retrospective cohort study
Genetic architecture distinguishes systemic juvenile idiopathic arthritis from other forms of juvenile idiopathic arthritis: clinical and therapeutic implications
Novel IL10 gene family associations with systemic juvenile idiopathic arthritis
Extreme thrombocytosis in systemic juvenile idiopathic arthritis. A case report
Mouse models of systemic juvenile idiopathic arthritis and macrophage activation syndrome
The role of extracellular histones in systemic-onset juvenile idiopathic arthritis
Tocilizumab-induced hypofibrinogenemia in patients with systemic-onset juvenile idiopathic arthritis
Biologic switching patterns among children with non-systemic juvenile idiopathic arthritis
The epigenetic determinants for systemic juvenile idiopathic arthritis phenotyping and treatment response
Oral or Parenteral Methotrexate for treatment of Non- Systemic Juvenile Idiopathic Arthritis
Inflammatory bowel disease following anti-interleukin-1-treatment in systemic juvenile idiopathic arthritis
Sequential Tocilizumab and Tofacitinib Treatment for Systemic Juvenile Idiopathic Arthritis: a Case Report
Systemic juvenile idiopathic arthritis in French Afro-Caribbean children, a retrospective cohort study
Genetic architecture distinguishes systemic juvenile idiopathic arthritis from other forms of juvenile idiopathic arthritis: clinical and therapeutic implications
Novel IL10 gene family associations with systemic juvenile idiopathic arthritis
Extreme thrombocytosis in systemic juvenile idiopathic arthritis. A case report
Mouse models of systemic juvenile idiopathic arthritis and macrophage activation syndrome
The role of extracellular histones in systemic-onset juvenile idiopathic arthritis
Tocilizumab-induced hypofibrinogenemia in patients with systemic-onset juvenile idiopathic arthritis
Biologic switching patterns among children with non-systemic juvenile idiopathic arthritis
The epigenetic determinants for systemic juvenile idiopathic arthritis phenotyping and treatment response
Oral or Parenteral Methotrexate for treatment of Non- Systemic Juvenile Idiopathic Arthritis
Inflammatory bowel disease following anti-interleukin-1-treatment in systemic juvenile idiopathic arthritis
Sequential Tocilizumab and Tofacitinib Treatment for Systemic Juvenile Idiopathic Arthritis: a Case Report